Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Accumulated Depreciation & Amortization (2020 - 2025)

Maxcyte (MXCT) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with -$15.6 million as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 11.83% to -$15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15.6 million through Dec 2025, up 11.83% year-over-year, with the annual reading at -$15.6 million for FY2025, 11.83% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was -$15.6 million at Maxcyte, down from -$3.8 million in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was -$3.5 million in Q2 2021, with the low at -$24.9 million in Q1 2023.
  • Average Accumulated Depreciation & Amortization over 5 years is -$10.7 million, with a median of -$8.8 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 305.07% in 2022, then surged 68.72% in 2024.
  • Over 5 years, Accumulated Depreciation & Amortization stood at -$5.6 million in 2021, then crashed by 155.76% to -$14.2 million in 2022, then soared by 37.65% to -$8.9 million in 2023, then crashed by 99.82% to -$17.7 million in 2024, then rose by 11.83% to -$15.6 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at -$15.6 million, -$3.8 million, and -$4.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.